Journal article
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs
Abstract
BACKGROUND: The efficacy and safety of anticoagulant treatment for patients with acute, symptomatic superficial-vein thrombosis in the legs, but without concomitant deep-vein thrombosis or symptomatic pulmonary embolism at presentation, have not been established.
METHODS: In a randomized, double-blind trial, we assigned 3002 patients to receive either fondaparinux, administered subcutaneously at a dose of 2.5 mg once daily, or placebo for 45 …
Authors
Decousus H; Prandoni P; Mismetti P; Bauersachs RM; Boda Z; Brenner B; Laporte S; Matyas L; Middeldorp S; Sokurenko G
Journal
The New England Journal of Medicine, Vol. 363, No. 13, pp. 1222–1232
Publisher
Massachusetts Medical Society
Publication Date
September 23, 2010
DOI
10.1056/nejmoa0912072
ISSN
0028-4793